DNA microarrays confirmed known FGFR2 amplification in KATOIII and SNU16 gastric cancer cell lines [23], [24] and identified a novel highly focal amplification in the NCI-H716 colorectal cancer cell line (Figure S1A in File S1. This evidence concerns the gene FGFR2 and colorectal cancer.